Brian HicksPosted December 10, 2013
Maybe you've been thinking about picking up a Coin all-in-one credit card. Here are some things to consider before picking one up.
Brian HicksPosted December 9, 2013
There's no doubt that there's a lot of money to be made in the biotech sector. But only those who are properly informed will make the most money.
Jason StutmanPosted December 9, 2013
While human medical knowledge and innovation have long been our greatest weapons against contagious diseases, those weapons could soon be turned against us.
Briton RylePosted December 9, 2013
Gold investors are flip-flopping from bearish to bullish and back again, and taper talks are stirring up even more confusion. What's in store for gold as the Fed prepares to scale back its stimulus?
Brian HicksPosted December 9, 2013
After the last government shutdown, Congress only pushed the debt limit off another couple months. And it's fast approaching just in time for the holidays...
Geoffrey PikePosted December 6, 2013
It's known as Obamacare, or the "Affordable Care Act." But it really should be called the UN-affordable Care Act. And when it comes to surviving the Unaffordable Care Act. you options are...
Briton RylePosted December 6, 2013
A move by Congress has the potential to lower the unemployment rate. Will this move the Fed to begin tapering its stimulus program earlier than expected?
Jason StutmanPosted December 6, 2013
Understanding disruptive trends is a critical component for any technology investor, as they will often indicate the winning and losing players in this space.
Brian HicksPosted December 6, 2013
What's more American than McDonald's and drone warfare? Both of them at the same time!
Brian HicksPosted December 6, 2013
Gold prices are unsteady, and the metal is going to end the year down. But it might also create a perfect buying opportunity...
Jason StutmanPosted December 6, 2013
Innovus Pharmaceuticals (OTC: INNV) exploded 40% during intra-day trading today...
Brian HicksPosted December 6, 2013
Small biotech companies are starting to give Big Pharma a run for its money. And IPOs are booming in current market conditions...